EGFR-Mutant Lung Cancer
1 clinical trials · Condition
◉ Watch EGFR-Mutant Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer (NCT01967095) | Memorial Sloan Kettering Cancer Center | 2013-10-15 |
Track EGFR-Mutant Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.